Vontobel Holding Ltd. Edwards Lifesciences Corp Transaction History

Vontobel Holding Ltd.

$29.2 Billion
Q3 2024

A detailed history of Vontobel Holding Ltd. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Vontobel Holding Ltd. holds 439,106 shares of EW stock, worth $32.8 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

439,106

Previous 415,546 5.67%

Holding current value

$32.8 Million

Previous $38.4 Million 24.51%

% of portfolio

0.1%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$59.7 - $93.78 $1.41 Million - $2.21 Million	23,560 Added 5.67%	439,106 $29 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $1.11 Million - $1.24 Million	-13,108 Reduced 3.06%	415,546 $38.4 Million
Q1 2024 May 10, 2024	SELL	$72.54 - $95.56 $22.8 Million - $30 Million	-313,921 Reduced 42.27%	428,654 $41 Million
Q4 2023 Jun 03, 2024	SELL	$61.71 - $77.76 $1.06 Million - $1.34 Million	-17,175 Reduced 4.13%	398,424 $30.4 Million
Q4 2023 Jan 29, 2024	SELL	$61.71 - $77.76 $2.12 Million - $2.67 Million	-34,315 Reduced 4.42%	742,575 $56.6 Million
Q3 2023 Jun 03, 2024	SELL	$69.28 - $93.38 $306,494 - $413,113	-4,424 Reduced 1.05%	415,599 $28.8 Million
Q3 2023 Oct 10, 2023	SELL	$69.28 - $93.38 $1.12 Million - $1.51 Million	-16,136 Reduced 2.03%	776,890 $53.8 Million
Q2 2023 Jun 03, 2024	BUY	$81.41 - $94.33 $2.32 Million - $2.69 Million	28,537 Added 7.29%	420,023 $39.6 Million
Q2 2023 Jul 24, 2023	BUY	$81.41 - $94.33 $5.2 Million - $6.02 Million	63,870 Added 8.76%	793,026 $74.8 Million
Q1 2023 Jun 03, 2024	SELL	$74.26 - $84.51 $2.76 Million - $3.14 Million	-37,168 Reduced 8.67%	391,486 $32.4 Million
Q1 2023 Apr 12, 2023	BUY	$74.26 - $84.51 $22.8 Million - $25.9 Million	306,664 Added 72.58%	729,156 $60.3 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $7.02 Million - $8.99 Million	102,822 Added 32.17%	422,492 $31.5 Million
Q3 2022 Nov 04, 2022	SELL	$82.37 - $107.29 $609,126 - $793,409	-7,395 Reduced 2.26%	319,670 $26.8 Million
Q2 2022 Jul 27, 2022	BUY	$86.5 - $128.27 $932,037 - $1.38 Million	10,775 Added 3.41%	327,065 $31.4 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $385,816 - $485,638	3,784 Added 1.21%	316,290 $37 Million
Q4 2021 Feb 14, 2022	BUY	$106.37 - $130.68 $5.39 Million - $6.62 Million	50,694 Added 19.36%	312,506 $40.8 Million
Q3 2021 Oct 29, 2021	BUY	$102.91 - $122.75 $1.94 Million - $2.31 Million	18,812 Added 7.74%	261,812 $29.6 Million
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $3.42 Million - $4.28 Million	40,823 Added 20.19%	243,000 $25.2 Million
Q1 2021 May 11, 2021	BUY	$78.68 - $90.67 $295,207 - $340,193	3,752 Added 1.89%	202,177 $16.9 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $14.2 Million - $18.1 Million	198,425 New	198,425 $17.1 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

457M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Account

Vontobel Holding Ltd. Edwards Lifesciences Corp Transaction History